Eris Lifesciences Enters Rs 30,000 Cr Injectables Market With Biocon Biologics Acquisition
Eris Lifesciences Enters Rs 30,000 Cr Injectables Market With Biocon Biologics Acquisition
The acquisition brings two leading insulin products, Basalog and Insugen, under Eris’s umbrella.
Indian branded formulations pharmaceutical…